Your session is about to expire
← Back to Search
99mTc-PYP Scan for Aortic Stenosis
Study Summary
This trial is testing a new way to detect a heart condition called transthyretin cardiac amyloidosis (TTR-CA) in people with aortic stenosis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a severe aortic stenosis with a valve area of 1.0 cm2 or less.You have been diagnosed with moderate or severe aortic stenosis based on a recent echocardiogram within the last 6 months.You live in one of these counties in Southeastern Minnesota: Olmsted, Dodge, Fillmore, Mower, Freeborn, Wabasha, or Steele.I had a heart attack within the last month confirmed by tests.Your aortic valve area is between 1.0 cm2 and 1.5 cm2.I have not had heart surgery or major chest injuries in the last 4 weeks.I am 75 years old or older.I have taken Plaquenil before.
- Group 1: SPECT/CT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participant count for this medical study?
"Affirmative. According to the information hosted on clinicaltrials.gov, this research endeavour is actively recruiting patients and was initially announced on November 1st 2022 with an edit made 10 days later. The study requires a total of 200 participants from just one medical facility."
Are any individuals being sought out to participate in this experiment?
"Yes, indeed. According to clinicaltrials.gov, this research study was first published on November 1st 2022 and the information was recently updated on the 10th of that month. The investigators need 200 participants across one medical centre for the trial's completion."
Share this study with friends
Copy Link
Messenger